Abstract
AbstractWe examined the hemodynamic profile of CK‐2289, a new imidazolone developed for the treatment of congestive heart failure, in the normal pentobarbital‐anesthetized dog. Mongrel dogs (10–18 kg) of either sex were anesthetized with pentobarbital sodium (35 mg/kg, intravenously [i.v.]) and instrumented for routine hemodynamic measurements using an open‐chest, artificially ventilated preparation. Intravenous administration of CK‐2289 (3, 10, 30, and 100 μ/kg) to pentobarbital‐anesthetized dogs increased left ventricular (LV) dP/dTmax by 9, 26, 73, and 80%, respectively, and decreased mean arterial pressure (MAP) by 2, 6, 18, and 34%. CK‐2289 was 2.7 times more potent as a positive inotropic agent than as a vasodilator. Heart rate (HR) increased by 2, 10, 18, and 28% after these doses of CK‐2289, while left ventricular end diastolic pressure (LVEDP) decreased by 4.5 mmHg after the highest dose of compound. CK‐2289 increased coronary blood flow (CBF) after each dose of compound. However, the increased CBF was less than that produced by milrinone for equivalent increases in LV dP/dTmax. Renal blood flow increased while vertebral blood flow was reduced after administration of the two highest doses of CK‐2289. However, vertebral vascular resistance decreased slightly from control values. Milrinone and enoximone behaved qualitatively similar to, but were 6 and 27 times less potent than CK‐2289 as cardiotonic agents. Thus, CK‐2289 is a mixed positive inotrope and vasodilator with a hemodynamic profile similar to milrinone and enoximone, which sugests it may have utility in the treatment of heart failure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.